The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

An Overview of the HYBRID Study in Elderly Patients With Bladder Cancer

Robert Huddart
Published Online:6:25 PM, Mon March 6, 2017

Robert Huddart, professor, The Institute of Cancer Research, discusses the HYBRID trial which assessed hypofractionated bladder radiotherapy with or without image guided adaptive planning in elderly patients with bladder cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.